Paeds · endocrinology-diabetes-and-growth
Type 1 diabetes: diagnosis and initial management
Also known as New-onset type 1 diabetes · Type 1 diabetes mellitus diagnosis · Islet autoantibodies · C-peptide · Diabetes staging · Partial remission · Honeymoon phase · Initial insulin therapy · Diabetes at presentation · Newly diagnosed diabetes in children
Fellowship guide to the diagnosis and first days of type 1 diabetes in children and adolescents who present without ketoacidosis: the classic symptoms and the diagnostic glucose and HbA1c thresholds, the islet autoantibodies and C-peptide that confirm the autoimmune type and separate it from type 2 and monogenic diabetes, the three-stage model of preclinical to clinical disease, the first subcutaneous basal-bolus insulin regimen, structured family education, and the honeymoon phase. The full ketoacidosis protocol lives on its own leaf.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- A child with polyuria, polydipsia and weight loss has diabetes until proven otherwise — check a finger-prick glucose the same day rather than waiting for a fasting test
- Kussmaul breathing, vomiting, abdominal pain or drowsiness at presentation means ketoacidosis, not uncomplicated new-onset diabetes — divert immediately to the DKA pathway
- Never send a symptomatic hyperglycaemic child home to wait for antibody or C-peptide results — start insulin and educate the family the same day, because the tests confirm the type but do not delay treatment
- New-onset diabetes in an infant under six months is neonatal (monogenic) diabetes, not type 1, and may respond to a sulfonylurea rather than lifelong insulin
- Insulin is never stopped in the honeymoon phase, however small the dose — a family who believes the diabetes has resolved is the classic route back to ketoacidosis
- A well child found to have two or more islet autoantibodies has preclinical (stage 1 or 2) type 1 diabetes and needs surveillance and family education, not reassurance that nothing is wrong
Life stages
Care settings
Clinical exam formats
Board mappings
- Diagnosis and initial management of type 1 diabetes
- New-onset type 1 diabetes: diagnosis, classification and first management
- Type 1 diabetes: autoantibodies, staging and initial insulin therapy
- Long case: the newly diagnosed child with type 1 diabetes
- Diabetes mellitus: presentation, diagnosis and initial management
- Diagnosis and classification of diabetes in children
- New presentation of diabetes: assessment and initial management
- Type 1 diabetes mellitus: diagnosis and initial care
- Patient Care: diagnosis and initial management of new-onset type 1 diabetes
- Medical Expert: type 1 diabetes diagnosis and initial management
This page covers the moment a child is found to have type 1 diabetes and the first days that follow, in the common situation where the child presents unwell with hyperglycaemia but without ketoacidosis. It works through how the diagnosis is made and confirmed, how the autoimmune type is separated from type 2 and monogenic diabetes, and how the first insulin regimen and family education are set up. The full ketoacidosis protocol and the ongoing ambulatory care each live on their own dedicated leaf. [10] [6]
Overview & Definition
Type 1 diabetes is an autoimmune disease in which the body destroys its own insulin-producing beta cells until the child can no longer make enough insulin to live. When enough beta cells are lost, glucose rises, the classic symptoms appear, and the child needs exogenous insulin from that day forward. Diagnosis is the act of recognising that picture and confirming it, and initial management is the safe start of insulin and the education that lets a family take the disease home. [10] [5]
Most children present at stage 3, the clinical onset, with a short history of thirst, frequent urination and weight loss. The task at that first contact is twofold: confirm the diagnosis quickly with a glucose measurement, and decide at once whether the child has simple hyperglycaemia or has tipped into ketoacidosis, because that single fork decides everything that follows. [10] [8]
References11ShowHide
- [1]Haller MJ; Bell KJ; et al ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr, 2024.PMID 39662065
- [2]Insel RA; Dunne JL; et al Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care, 2015.PMID 26404926
- [3]Ziegler AG; Rewers M; et al Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA, 2013.PMID 23780460
- [4]Leighton E; Sainsbury CA; Jones GC A Practical Review of C-Peptide Testing in Diabetes. Diabetes Ther, 2017.PMID 28484968
- [5]Couper JJ; Haller MJ; et al ISPAD Clinical Practice Consensus Guidelines 2018: Stages of type 1 diabetes in children and adolescents. Pediatr Diabetes, 2018.PMID 30051639
- [6]Cengiz E; Danne T; et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. Horm Res Paediatr, 2024.PMID 39884261
- [7]de Bock M; Agwu JC; et al International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Glycemic Targets. Horm Res Paediatr, 2024.PMID 39701064
- [8]Phelan H; Hanas R; et al Sick day management in children and adolescents with diabetes. Pediatr Diabetes, 2022.PMID 36093857
- [9]Herold KC; Bundy BN; et al An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med, 2019.PMID 31180194
- [10]DiMeglio LA; Evans-Molina C; Oram RA Type 1 diabetes. Lancet, 2018.PMID 29916386
- [11]Lawrence JM; Divers J; et al Trends in Prevalence of Type 1 and Type 2 Diabetes in Children and Adolescents in the US, 2001-2017. JAMA, 2021.PMID 34427600